Cuproplasia characterization in colon cancer assists to predict prognosis and immunotherapeutic response

INTRODUCTION: Colon cancer is the 3(rd) most prevalent cancer worldwide, with more than 900,000 deaths annually. Chemotherapy, targeted treatment, and immunotherapeutic treatment are the three cornerstones of colon cancer treatment; however, the occurrence of immune therapy resistance is the most pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bomiao, Li, Yien, Song, Liqiang, Xi, Hua, Wang, Shaoke, Yu, Chenfeng, Cui, Binbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060792/
https://www.ncbi.nlm.nih.gov/pubmed/37007132
http://dx.doi.org/10.3389/fonc.2023.1061084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060792/
https://www.ncbi.nlm.nih.gov/pubmed/37007132
http://dx.doi.org/10.3389/fonc.2023.1061084

Ejemplares similares